Long-Term Health Care Utilization Costs of GLP-1RA Use vs Bariatric Metabolic Surgery - Takeaways - MDSpire

Long-Term Health Care Utilization Costs of GLP-1RA Use vs Bariatric Metabolic Surgery

  • By

  • Yael Wolff Sagy

  • Eitan Ernest Winter

  • Wiessam Abu Ahmad

  • Erez Battat

  • Ronen Arbel

  • Orna Reges

  • Dror Dicker

  • Gil Lavie

  • July 1, 2026

  • 0 min

Share

  • 1

    Obesity and type 2 diabetes pose significant public health challenges, with obesity-related costs in the US estimated at $260 billion in 2021.

  • 2

    Bariatric metabolic surgery and GLP-1 receptor agonists are effective interventions for managing obesity and its complications.

  • 3

    The study assesses long-term healthcare costs for patients treated with GLP-1RAs versus those who underwent bariatric surgery.

  • 4

    Participants included adults with obesity and diabetes from Clalit Health Services, followed for up to 12.5 years.

  • 5

    The primary outcome measured was overall healthcare costs, excluding direct treatment costs, reflecting economic impacts.

Original Source(s)

Long-Term Health Care Utilization Costs of GLP-1RA Use vs Bariatric Metabolic Surgery

  • by Yael Wolff Sagy, Eitan Ernest Winter, Wiessam Abu Ahmad, Erez Battat, Ronen Arbel, Orna Reges, Dror Dicker, Gil Lavie

  • July 1, 2026

Related Content

Judge rules government can’t stop SNAP dollars from buying candy and sugary drinks

Weight Loss, Comorbidity, and Complications After Single-anastomosis Sleeve Ileal Bypass (SASI): A Systematic Review and Meta-analysis

Vitamin D in the UK: an urgent call to redefine the threshold for deficiency